This is the Continuous Integration Build of FHIR (will be incorrect/inconsistent at times).
See the Directory of published versions 
Clinical Decision Support Work Group |
Maturity Level: 1 | Trial Use | Use Context: Country: World |
Official URL: http://hl7.org/fhir/ValueSet/study-design-example
|
Version: 6.0.0-ballot3 | |||
| draft as of 2022-08-24 | Computable Name: StudyDesignExample | |||
| Flags: Immutable | OID: | |||
This value set is used in the following places:
This is a set of terms for study design characteristics.
Generated Narrative: ValueSet study-design-example
Last updated: 2025-11-01T11:50:33Z
Profile: Shareable ValueSet
http://hl7.org/fhir/study-design-example version 📦6.0.0-ballot3
This expansion generated 01 Nov 2025
ValueSet
Expansion performed internally based on codesystem Study Design Example v6.0.0-ballot3 (CodeSystem)
This value set contains 72 concepts
| Level | System | Code | Display |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01001 | Interventional research |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01003 | randomized assignment |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01006 | simple randomization |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01007 | stratified randomization |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01008 | block randomization |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01009 | adaptive randomization |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01005 | Non-randomized assignment |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01004 | Quasi-Randomized assignment |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01029 | Clinical trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01041 | Pragmatic clinical trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01038 | Expanded Access study |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01030 | Phase 1 trial |
| 4 | http://hl7.org/fhir/study-design-example |
SEVCO:01031 | Exploratory investigational new drug study |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01032 | Phase 1/Phase 2 trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01033 | Phase 2 trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01034 | Phase 2/Phase 3 trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01035 | Phase 3 trial |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01036 | Post-marketing study |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01002 | Observational research |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01037 | Post-Marketing Surveillance study |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01010 | Comparative study design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01011 | Parallel cohort design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01012 | Crossover cohort design |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01024 | Controlled crossover cohort design |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01025 | Single-arm crossover design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01013 | Case control design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01014 | Matching for comparison |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01020 | Family study design |
| 4 | http://hl7.org/fhir/study-design-example |
SEVCO:01021 | Twin study design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01015 | Cluster as unit of allocation |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01023 | Non-comparative study design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01016 | Uncontrolled cohort design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01017 | Case report |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01022 | Population-based design |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01044 | Ecological design |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01027 | Cross sectional data collection |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01028 | Longitudinal data collection |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01018 | Time series design |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01019 | Before and after comparison |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01045 | Primary data collection |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01026 | Real world data collection |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01039 | Real world data collection from healthcare records |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01050 | Real world data collection from personal health records |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01040 | Real world data collection from healthcare financing records |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01048 | Real world data collection from testing procedures |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01046 | Real world data collection from monitoring procedures |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01049 | Secondary data collection from prior research |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01042 | Secondary data collection from a registry |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01051 | Multisite data collection |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01086 | Quantitative analysis |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01087 | Qualitative analysis |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01060 | Blinding of study participants |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01061 | Blinding of intervention providers |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01062 | Blinding of outcome assessors |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01063 | Blinding of data analysts |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01064 | Allocation concealment |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01043 | Multicentric |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01052 | Includes patient-reported outcome |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01053 | Includes patient-centered outcome |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01054 | Includes disease-oriented outcome |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01085 | Includes process measure |
| 1 | http://hl7.org/fhir/study-design-example |
SEVCO:01089 | Study Goal |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01096 | Evaluation Goal |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01097 | Derivation Goal |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01098 | Validation Goal |
| 2 | http://hl7.org/fhir/study-design-example |
SEVCO:01088 | Comparison Goal |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01091 | Comparative Effectiveness Goal |
| 4 | http://hl7.org/fhir/study-design-example |
SEVCO:01090 | Comparative Efficacy Goal |
| 4 | http://hl7.org/fhir/study-design-example |
SEVCO:01092 | Comparative Safety Goal |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01093 | Equivalence Goal |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01094 | Non-inferiority Goal |
| 3 | http://hl7.org/fhir/study-design-example |
SEVCO:01095 | Superiority Goal |
See the full registry of value sets defined as part of FHIR.
Explanation of the columns that may appear on this page:
| Lvl | A few code lists that FHIR defines are hierarchical - each code is assigned a level. For value sets, levels are mostly used to organize codes for user convenience, but may follow code system hierarchy - see Code System for further information |
| Source | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
| Code | The code (used as the code in the resource instance). If the code is in italics, this indicates that the code is not selectable ('Abstract') |
| Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
| Definition | An explanation of the meaning of the concept |
| Comments | Additional notes about how to use the code |